Published in Leukemia on August 26, 2010
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia. J Clin Invest (2015) 0.96
Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia. Proteome Sci (2011) 0.85
Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome. Proteome Sci (2012) 0.83
Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome. Proteome Sci (2013) 0.81
Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway. Leuk Res Treatment (2012) 0.79
Peripheral blood mononuclear cell proteome changes in patients with myelodysplastic syndrome. Biomed Res Int (2015) 0.75
Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups. Biomed Res Int (2015) 0.75
A physical map of the human genome. Nature (2001) 12.39
EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett (2000) 4.96
Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature (1992) 4.68
Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature (1990) 3.29
The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood (2001) 2.77
Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol (2003) 2.58
Cutaneous vasculitis in patients with myelodysplasia. Br J Haematol (1990) 2.33
Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem (1992) 2.31
MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci U S A (1997) 2.01
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet (1999) 1.96
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. Leukemia (2004) 1.90
A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data. Math Biosci (2003) 1.81
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood (1997) 1.71
Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene (2001) 1.68
Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood (1995) 1.64
Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes. Leukemia (2002) 1.59
Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res (2001) 1.57
A novel 3D wavelet-based filter for visualizing features in noisy biological data. J Microsc (2005) 1.50
Inhibitor of stem cell proliferation in normal bone marrow. Br J Haematol (1976) 1.50
Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239. Br J Cancer (1998) 1.50
Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol (1997) 1.46
The p53 response to ionising radiation in adult and developing murine tissues. Oncogene (1996) 1.46
New insights into the biology of Philadelphia-chromosome-positive acute lymphoblastic leukaemia using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level. Br J Haematol (1997) 1.43
Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond--9th European Hematology Association Congress Geneva, Switzerland, 10-13 June 2004. Transfus Med (2007) 1.40
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. Leukemia (2011) 1.38
A stimulator of stem cell proliferation in regenerating bone marrow. Biomedicine (1977) 1.38
Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood (2001) 1.36
Chromosomal instability in the descendants of unirradiated surviving cells after alpha-particle irradiation. Proc Natl Acad Sci U S A (1998) 1.35
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia (2008) 1.35
Chromosomal instability in unirradiated cells induced in vivo by a bystander effect of ionizing radiation. Cancer Res (2000) 1.31
Radiation-induced genomic instability and persisting oxidative stress in primary bone marrow cultures. Carcinogenesis (1996) 1.27
Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo. Blood (1992) 1.27
Characterisation of the promoter region of the human DNA-repair gene Rad51. Eur J Gynaecol Oncol (2005) 1.27
The regulation of hemopoiesis in long-term bone marrow cultures. II. Stimulation and inhibition of stem cell proliferation. Blood (1980) 1.25
Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. Leukemia (2007) 1.21
Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. Br J Haematol (2001) 1.21
Individual variation in the production of a 'bystander signal' following irradiation of primary cultures of normal human urothelium. Carcinogenesis (2001) 1.19
Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia (2000) 1.18
Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo. Oncogene (2001) 1.14
Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica (1998) 1.12
In vivo chromosomal instability and transmissible aberrations in the progeny of haemopoietic stem cells induced by high- and low-LET radiations. Int J Radiat Biol (2001) 1.08
Chronic intestinal ischaemia. Br Med J (1967) 1.08
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. Genomics (1997) 1.05
Regulation of haemopoietic stem cell proliferation in long term bone marrow cultures. Biomedicine (1977) 1.04
Radiation-induced genomic instability: delayed cytogenetic aberrations and apoptosis in primary human bone marrow cells. Int J Radiat Biol (1995) 1.04
Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24-->q25 by in situ hybridization. Cytogenet Cell Genet (1998) 1.03
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks. Leukemia (2006) 1.03
A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer (2000) 1.02
Alpha-particle-induced chromosomal instability in human bone marrow cells. Lancet (1994) 1.01
Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci U S A (1996) 1.00
Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA. Leukemia (2007) 0.99
Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia (2001) 0.98
Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol (2005) 0.98
The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage. Oncogene (2012) 0.97
A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation? Leukemia (2009) 0.97
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance. Leukemia (2012) 0.96
Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma. Leukemia (2006) 0.96
Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure. Blood (2000) 0.95
The effect of stem cell proliferation regulators demonstrated with an in vitro assay. Blood (1988) 0.95
Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia (2003) 0.94
Stable and reproducible engraftment of primary adult and pediatric acute myeloid leukemia in NSG mice. Leukemia (2011) 0.94
Genetic factors influencing alpha-particle-induced chromosomal instability. Int J Radiat Biol (1997) 0.94
Comparative validation of single-shot optical techniques for laparoscopic 3-D surface reconstruction. IEEE Trans Med Imaging (2014) 0.94
Complex chromosome aberrations in peripheral blood lymphocytes as a potential biomarker of exposure to high-LET alpha-particles. Int J Radiat Biol (2000) 0.93
Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J Exp Med (1994) 0.93
Assessing radiation-associated mutational risk to the germline: repetitive DNA sequences as mutational targets and biomarkers. Radiat Res (2006) 0.93
Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis? Ann Hematol (2007) 0.92
TEGDMA causes apoptosis in primary human gingival fibroblasts. J Dent Res (2003) 0.92
Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Ann Rheum Dis (2007) 0.92
Analysis of NUP98/NSD1 translocations in adult AML and MDS patients. Leukemia (2012) 0.92
Heavy metals of relevance to human health induce genomic instability. J Pathol (2001) 0.92
Frequent deletions of 6q23-24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization. Genes Chromosomes Cancer (1997) 0.91
An E mu-BCL-2 transgene facilitates leukaemogenesis by ionizing radiation. Oncogene (1999) 0.91
Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice. Int J Radiat Oncol Biol Phys (1991) 0.90
Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Haematologica (2001) 0.90
Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-alpha concentration. Br J Haematol (1997) 0.90
Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells. Br J Cancer (2003) 0.90
The genetic basis of tissue responses to ionizing radiation. Br J Radiol (2007) 0.90
[Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD]. Zentralbl Gynakol (2003) 0.90
Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1? Blood (1998) 0.89
Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. J Clin Oncol (1996) 0.89
Dose- and time-response relationships for lethal mutations and chromosomal instability induced by ionizing radiation in an immortalized human keratinocyte cell line. Int J Radiat Biol (2000) 0.89
Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome. Leukemia (2007) 0.89
Synergistic interactions allow colony formation in vitro by murine haemopoietic stem cells. Leuk Res (1990) 0.88
An inhibitor of murine stem cell proliferation produced by normal human bone marrow. Leuk Res (1980) 0.88
Low-dose melphalan in elderly acute myeloid leukaemia: complete remissions but resistant relapse with therapy-related karyotypes. Leukemia (2000) 0.88
Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas. Ann Oncol (1998) 0.88
Regulation of murine granulocyte-macrophage progenitor cell and haemopoietic stem cell proliferation by factors produced in human fetal liver. Leuk Res (1982) 0.88
Long-term in vivo transmission of alpha-particle-induced chromosomal instability in murine haemopoietic cells. Int J Radiat Biol (1996) 0.88
The submucous cleft palate: diagnosis and therapy. Int J Pediatr Otorhinolaryngol (2010) 0.87
Specific inhibition of haemopoietic stem cell proliferation: characteristics of the inhibitor producing cells. Leuk Res (1980) 0.87
Stimulation of haemopoietic stem cell proliferation: characteristics of the stimulator-producing cells. Leuk Res (1982) 0.87